Literature DB >> 7473487

Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity.

R W McMurray1, S H Allen, P H Pepmueller, D Keisler, J T Cassidy.   

Abstract

OBJECTIVE: To determine if antinuclear antibody seropositivity in girls with juvenile rheumatoid arthritis (JRA) is associated with elevated serum levels of the anterior pituitary hormone prolactin.
METHODS: Nineteen premenarchal girls meeting ACR classification criteria for JRA were evaluated for disease activity, antinuclear antibodies (ANA) seropositivity, and serum concentrations of prolactin, estrogen, and thyroid stimulating hormone.
RESULTS: The mean serum prolactin concentration of ANA seropositive patients with JRA (10.9 +/- 1.9 micrograms/l) was significantly higher than that for ANA negative patients (5.7 +/- 1.0 micrograms/l; p = 0.043) and an age matched control group (5.8 +/- 1.3 micrograms/l; p = 0.048).
CONCLUSION: Children with ANA seropositive JRA have elevated serum levels of the immunostimulatory hormone prolactin.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473487

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  4 in total

Review 1.  Hypophyseal-pituitary-adrenal axis in autoimmune and rheumatic diseases.

Authors:  B H Athreya; P Rettig; W V Williams
Journal:  Immunol Res       Date:  1998       Impact factor: 2.829

2.  Low cortisol levels in active juvenile idiopathic arthritis.

Authors:  Yelda Bilginer; Rezan Topaloglu; Ayfer Alikasifoglu; Nazli Kara; Nesrin Besbas; Seza Ozen; Aysin Bakkaloglu
Journal:  Clin Rheumatol       Date:  2009-12-15       Impact factor: 2.980

3.  Prevalence of autoimmune disease in patients with prolactinomas and non-functioning pituitary adenomas.

Authors:  V Larouche; J A Correa; P Cassidy; C Beauregard; N Garfield; J Rivera
Journal:  Pituitary       Date:  2016-04       Impact factor: 4.107

Review 4.  Prolactin and autoimmunity.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Carmen Navarro
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.